Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD (ADXN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
04/16/2018 04/17/2018 04/18/2018 04/19/2018 04/20/2018 Date
3.44(c) 3.4(c) 3.41(c) 3.41(c) 3.33(c) Last
125 496 59 414 31 470 98 925 41 633 Volume
+3.93% -1.16% +0.29% 0.00% -2.35% Change
More quotes
Company
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health.It develops novel, orally available, and small molecule allosteric modulators for neurological disorders.The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
03/30ADDEX THERAPEUTICS : Sucessfully Raises CHF40 million in Capital Increase
AQ
03/29ADDEX THERAPEUTICS : Sucessfully Raises CHF40 million in Capital Increase
GL
03/29ADDEX THERAPEUTICS : Sucessfully Raises CHF40 million in Capital Increase
AQ
03/20ADDEX THERAPEUTICS : Swiss Takeover Board Validates New Article 39 (Opting-Out P..
GL
03/19ADDEX THERAPEUTICS : Shareholders Approved all Board Proposals at Extraordinary ..
GL
03/05ADDEX THERAPEUTICS : Secures Investor Commitment for CHF40 million Capital Incre..
GL
02/23ADDEX THERAPEUTICS : Publishes Extraordinary General Meeting Invitation
GL
02/16ADDEX THERAPEUTICS : Launches CHF40 million Capital Increase with Commitment fro..
AQ
02/15ADDEX THERAPEUTICS : Launches CHF40 million Capital Increase with Commitment fro..
GL
02/15ADDEX THERAPEUTICS : Launches CHF40 million Capital Increase with Commitment fro..
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
04/215:55 PM- Brief gusty winds will be possible across western parts of Beckham a.. 
04/18Red Flag Warning for Harper, Woods, Alfalfa, Ellis, Woodward, Major, Roger Mi..
1
04/16Red Flag Warning for Harper, Ellis, Woodward, Roger Mills, Dewey, Custer, Was.. 
04/15Red Flag Warning for Harper, Ellis, Woodward, Roger Mills, Dewey, Custer, Was.. 
04/15Red Flag Watch for Harper, Ellis, Woodward, Roger Mills, Dewey, Custer, Washi.. 
More tweets
Qtime:103
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Managers
NameTitle
Timothy Dyer Chief Executive Officer & Director
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD45.41%98
CELLTRION, INC.--.--%31 467
IQVIA HOLDINGS INC-0.64%20 258
LONZA GROUP-6.95%18 703
INCYTE CORPORATION-27.75%14 493
NEKTAR THERAPEUTICS44.36%13 873